CytoDyn Announces Execution of Exclusive Agreement with American Regent for Distribution and Supply of Leronlimab for Treatment of COVID-19 in United StatesGlobeNewsWire • 07/06/20
CytoDyn Releases Mechanism of Action Animation for Leronlimab in Immuno-OncologyGlobeNewsWire • 07/02/20
CytoDyn and NIH of Mexico Complete Memorandum of Understanding to Conduct Small Covid-19 Phase 3 Trial for Severe and Critically Ill PatientsGlobeNewsWire • 06/29/20
CytoDyn Initiates Phase 2 Clinical Trial With Leronlimab for Treatment of NASHGlobeNewsWire • 06/11/20
CytoDyn Reached Its Enrollment Target for Phase 2 COVID-19 Trial for Mild to Moderate Indication – Primary End Point Announcement Is NextGlobeNewsWire • 06/11/20
5 Biotech Stocks in Focus as Race for Coronavirus Vaccine Heats UpZacks Investment Research • 05/19/20
CytoDyn moves forward with mid-stage trial for experimental COVID-19 treatmentMarket Watch • 03/31/20
CytoDyn May Be One Of The First Biotechs To Have A Drug That Helps Against Covid-19Seeking Alpha • 03/28/20